Thomas Schall

850 total citations
8 papers, 703 citations indexed

About

Thomas Schall is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Thomas Schall has authored 8 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Thomas Schall's work include Chemokine receptors and signaling (3 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Breastfeeding Practices and Influences (1 paper). Thomas Schall is often cited by papers focused on Chemokine receptors and signaling (3 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Breastfeeding Practices and Influences (1 paper). Thomas Schall collaborates with scholars based in United Kingdom, Mali and United States. Thomas Schall's co-authors include Antal Rot, Odile Devergne, Michel Peuchmaur, Marie‐Claude Crevon, Thomas J. Schall, M D Sadick, Anne Marfaing‐Koka, Colin Michie, Ivan Lindley and Hisayuki Nomiyama and has published in prestigious journals such as The Journal of Experimental Medicine, Gastroenterology and European Journal of Immunology.

In The Last Decade

Thomas Schall

8 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Schall United Kingdom	6	440	349	81	73	72	8	703
John Y. Mak United States	7	495 1.1×	385 1.1×	126 1.6×	66 0.9×	174 2.4×	8	1.1k
Dorit Fabricius Germany	13	710 1.6×	243 0.7×	36 0.4×	60 0.8×	80 1.1×	33	1.0k
Kazuhiro Tomizawa Japan	11	228 0.5×	204 0.6×	40 0.5×	74 1.0×	102 1.4×	18	586
Ron P. Gladue United States	8	327 0.7×	187 0.5×	54 0.7×	21 0.3×	85 1.2×	8	553
Katja Brandt Germany	11	738 1.7×	202 0.6×	27 0.3×	56 0.8×	100 1.4×	12	907
Renata Mazzucchelli Italy	11	774 1.8×	249 0.7×	36 0.4×	66 0.9×	91 1.3×	13	1.1k
A.D. Donnenberg United States	16	618 1.4×	264 0.8×	75 0.9×	151 2.1×	144 2.0×	38	1.2k
Katja C. Beier Germany	9	1.3k 3.0×	355 1.0×	84 1.0×	177 2.4×	79 1.1×	11	1.6k
L. S. Hair United States	10	680 1.5×	133 0.4×	69 0.9×	64 0.9×	88 1.2×	15	1.0k
Stefanie Willenzon Germany	10	617 1.4×	237 0.7×	33 0.4×	79 1.1×	96 1.3×	17	843

Countries citing papers authored by Thomas Schall

Since Specialization

Citations

This map shows the geographic impact of Thomas Schall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schall more than expected).

Fields of papers citing papers by Thomas Schall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schall. The network helps show where Thomas Schall may publish in the future.

Co-authorship network of co-authors of Thomas Schall

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schall. A scholar is included among the top collaborators of Thomas Schall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schall. Thomas Schall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Miao, Zhenhua, Dale Newland, Linda Ertl, et al.. (2016). Reduction of Liver Fibrosis by CCR2 Antagonist CCX872 in Murine Models of NASH. The American Journal of Gastroenterology. 111. S398–S398. 2 indexed citations

2.

Jung, Heiyoun, A. Bischof, Karen Ebsworth, et al.. (2015). Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer. Journal for ImmunoTherapy of Cancer. 3(S2). 15 indexed citations

3.

Keshav, Satish, Daniel H. Johnson, Thomas Schall, & Pirow Bekker. (2010). 647 Chemokine Receptor Antagonist CCX282-B (Traficet-En™) Maintained Remission of Crohn's Disease in PROTECT-1 Study. Gastroenterology. 138(5). S–86. 6 indexed citations

4.

Bacon, Kevin B., Hal E. Broxmeyer, Richard Horuk, et al.. (2002). Chemokine/Chemokine Receptor Nomenclature. Journal of Interferon & Cytokine Research. 22(10). 1067–1068. 279 indexed citations

5.

Papadopoulos, Elektra J., Hidehisa Saeki, Nobuo Yamada, et al.. (1999). Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. European Journal of Immunology. 29(8). 2551–2559. 137 indexed citations

6.

Michie, Colin, et al.. (1998). Physiological secretion of chemokines in human breast milk.. PubMed. 9(2). 123–9. 69 indexed citations

7.

Devergne, Odile, Anne Marfaing‐Koka, Thomas J. Schall, et al.. (1994). Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.. The Journal of Experimental Medicine. 179(5). 1689–1694. 194 indexed citations

8.

Fish, Eleanor N., Elizabeth Robinson, Ed Keystone, & Thomas Schall. (1994). Chemokine expression in rheumatoid arthritis. Cytokine. 6(5). 581–581. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact